| Literature DB >> 22936930 |
Edith Coronado1, Clémence Roggo, David R Johnson, Jan Roelof van der Meer.
Abstract
Sphingomonas wittichii RW1 is a bacterium isolated for its ability to degrade the xenobiotic compounds dibenzodioxin and dibenzofuran (DBF). A number of genes involved in DBF degradation have been previously characterized, such as the dxn cluster, dbfB, and the electron transfer components fdx1, fdx3, and redA2. Here we use a combination of whole genome transcriptome analysis and transposon library screening to characterize RW1 catabolic and other genes implicated in the reaction to or degradation of DBF. To detect differentially expressed genes upon exposure to DBF, we applied three different growth exposure experiments, using either short DBF exposures to actively growing cells or growing them with DBF as sole carbon and energy source. Genome-wide gene expression was examined using a custom-made microarray. In addition, proportional abundance determination of transposon insertions in RW1 libraries grown on salicylate or DBF by ultra-high throughput sequencing was used to infer genes whose interruption caused a fitness loss for growth on DBF. Expression patterns showed that batch and chemostat growth conditions, and short or long exposure of cells to DBF produced very different responses. Numerous other uncharacterized catabolic gene clusters putatively involved in aromatic compound metabolism increased expression in response to DBF. In addition, only very few transposon insertions completely abolished growth on DBF. Some of those (e.g., in dxnA1) were expected, whereas others (in a gene cluster for phenylacetate degradation) were not. Both transcriptomic data and transposon screening suggest operation of multiple redundant and parallel aromatic pathways, depending on DBF exposure. In addition, increased expression of other non-catabolic genes suggests that during initial exposure, S. wittichii RW1 perceives DBF as a stressor, whereas after longer exposure, the compound is recognized as a carbon source and metabolized using several pathways in parallel.Entities:
Keywords: bioremediation; microarray analysis; polycyclic aromatic hydrocarbons; transposon screening
Year: 2012 PMID: 22936930 PMCID: PMC3425912 DOI: 10.3389/fmicb.2012.00300
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
RW1 gene cluster representatives for putative aromatic compound metabolism with significantly changed expression levels or proportional abundances in transposon libraries.
| Cluster | Swit Locus | Name or gene name | Strand | Tn library | Expression, fold change | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TN01 | SAL | DBF | SAL/PHE | SAL/DBF | DBF/PHE | DBF shock | Chemostat shift | |||||||
| 30 m | 1 h | 2 h | 6 h | |||||||||||
| 310–312 | 311 | Carboxymuconolactone decarboxylase | 1.21 | 1.93 | 2.81 | 2.51 | 2.03 | 1.25 | ||||||
| 748-749 | 749 | Enoyl-CoA hydratase | 0.72 | 0.31 | 0.35 | 0.35 | 0.31 | |||||||
| 750–758 | 750 | 3-Hydroxyacyl-CoA dehydrogenase | 0.53 | 0.48 | 0.47 | 0.38 | 0.48 | |||||||
| 753 | 0.50 | 0.24 | ||||||||||||
| 754 | ||||||||||||||
| 755 | ||||||||||||||
| 756 | 1.06 | 1.66 | 1.72 | 1.51 | 1.45 | 1.01 | ||||||||
| 975–978 | 975 | Muconate cycloisomerase | 1.72 | 1.06 | 0.74 | 0.58 | 0.46 | 1.95 | ||||||
| 978 | 3-Oxoadipate enol-lactonase | 1.02 | 1.56 | 1.33 | 1.05 | 0.60 | 1.04 | |||||||
| 1639–1644 | 1639 | 4-Oxalocrotonate decarboxylase | 1.68 | 1.17 | 0.99 | 1.13 | 1.47 | 1.83 | ||||||
| 1643 | FMN-dependent alpha-hydroxy acid dehydrogenase | 1.27 | 0.92 | 1.13 | 1.08 | 1.10 | 1.05 | |||||||
| 1754–1760 | 1757 | Rieske-type protein; beta subunit | 0.95 | 0.74 | 0.96 | 0.86 | 0.81 | 0.80 | ||||||
| 1759 | Ferredoxin | 1.04 | 1.09 | 1.01 | 1.62 | 1.99 | ||||||||
| 1825–1830 | 1827 | Alpha/beta hydrolase fold protein | 1.05 | 1.36 | 1.71 | 1.54 | 1.61 | |||||||
| 1828 | Acyl-CoA dehydrogenase type 2 | 1.04 | 1.71 | |||||||||||
| 1829 | Rieske-type protein | 1.13 | 1.95 | |||||||||||
| 1847–1852 | 1848 | Putative extradiol dioxygenase | ||||||||||||
| 1860–1861 | 1861 | Dioxygenase motif | 1.54 | 0.77 | 1.69 | |||||||||
| 2634–2636 | 2634 | Benzoate 1,2-dioxygenase; alpha | 1.42 | 1.87 | ||||||||||
| 3055–3066 | 3055 | Alpha/beta hydrolase fold protein ( | 1.65 | 0.68 | 0.64 | 0.85 | 0.90 | |||||||
| 3056 | Rieske-type protein; alpha subunit (putative salicylate 5 hydroxylase) | 0.78 | 0.59 | 0.73 | 0.82 | |||||||||
| 3057 | Rieske; beta subunit | 1.07 | 0.64 | 0.51 | 0.57 | 0.57 | ||||||||
| 3058 | Maleylacetoacetate isomerase″ | 0.74 | 0.55 | 0.41 | 0.38 | 0.45 | ||||||||
| 3083–3084 | 3084 | 5-Oxopent-3-ene-1,2,5-tricarboxylate decarboxylase | 1.35 | 1.46 | 1.06 | 1.26 | 1.39 | 1.19 | ||||||
| 3085–3086 | 3086 | Gentisate 1,2-dioxygenase like protein | 1.49 | 1.32 | 1.51 | 1.53 | 1.07 | |||||||
| 3087–3096 | 3087 | 2,4-Dihydroxyhept-2-ene-1,7-dioic acid aldolase | 0.98 | 1.01 | 0.93 | 1.03 | 1.53 | |||||||
| 3094 | Putative extradiol dioxygenase | 1.85 | 1.72 | 1.28 | 0.96 | 0.93 | 1.10 | |||||||
| 3416–3418 | 3418 | Putative extradiol dioxygenase | 1.13 | 1.96 | 1.82 | |||||||||
| 3863–3865 | 3865 | 4-Hydroxyphenylpyruvate dioxygenase | 1.73 | 1.40 | 1.60 | |||||||||
| 4273 | 4273 | Vanillate monooxygenase | 1.13 | 1.20 | 1.25 | 1.87 | ||||||||
| 4278 | 4278 | Rieske-type protein; alpha subunit | 1.54 | 1.89 | 1.84 | 1.84 | ||||||||
| 4887–4897 | 4890 | Hydroxyquinol 1,2-dioxygenase ( | 1.17 | 1.26 | 0.92 | 0.88 | 0.85 | |||||||
| 4895 | Alpha/beta hydrolase fold | 1.29 | 0.90 | 1.16 | 0.93 | 1.34 | 1.40 | |||||||
| 4896 | Aromatic-ring-hydroxylating dioxygenase ( | 1.85 | 0.69 | 1.46 | 1.61 | 1.24 | ||||||||
| 4897 | Ring hydroxylating dioxygenase ( | 1.52 | 1.32 | 1.72 | 1.39 | |||||||||
| 4902 | 4902 | 0.79 | 0.46 | 0.46 | 0.67 | |||||||||
| 4922–4925 | 4923 | 4-Hydroxy-2-ketovalerate aldolase | 0.84 | 0.93 | 0.57 | 0.61 | 0.55 | |||||||
| 5101–5102 | 5101 | Monooxygenase, FAD binding | 0.80 | 0.94 | 0.68 | 0.52 | 1.10 | |||||||
| 5102 | Gentisate 1,2-dioxygenase | 0.82 | 1.19 | 1.16 | 1.19 | 1.16 | ||||||||
For expanded version, see Table S2 in Supplementary Material.
.
.
.
Figure 1(A) Hierarchical clustering of RW1 gene expression over all conditions generated by GENESPRING GX. Short refers to the short DBF exposure in batch cultures, Long to cells grown in batch cultures on DBF, and Chemostat refers to the transient exposure to DBF in continuously grown cultures. Color code: red, increased expression; blue, decreased expression. (B) Venn diagram (Hulsen et al., 2008) grouping the genes differentially expressed in the DBF exposure experiments compared to PHE-control conditions. Numbers represent genes exclusive for one condition, while the numbers in the intersections represent those occurring between two or more conditions.
Figure 2Proportional abundances of differentially expressed genes in conditions of DBF exposure compared to PHE, categorized per COG. (A) Short exposure to DBF in PHE-grown batch cultures, (B), transient exposure to DBF in chemostats, and (C) growth on DBF in batch culture. Note that (B) shows data sets from the four time points after addition of DBF to the chemostat (see inset).
Figure 3Growth of .
RW1 gene cluster representatives with significantly changed expression levels or proportional abundances in transposon libraries.
| Swit Locus | Name | Tn library | Expression, fold change | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TN01 | SAL | DBF | SAL/PHE | SAL/DBF | DBF/PHE | DBF shock | Chemostat shift | |||||
| 30 m | 1 h | 2 h | 6 h | |||||||||
| 0016 | Redoxin domain containing protein | 0.99 | 1.75 | |||||||||
| 0847 | Glutathione S-transferase domain containing protein | 1.82 | 1.89 | 1.34 | ||||||||
| 2245 | Glutathione S-transferase domain containing protein | 1.56 | ||||||||||
| 3730 | Catalase | 1.87 | 1.16 | |||||||||
| 3741 | 1-Cys peroxiredoxin | 1.60 | 1.67 | |||||||||
| 3743 | 1-Cys peroxiredoxin | 1.83 | 1.44 | |||||||||
| 3979 | ATP-dependent DNA ligase | 1.35 | 1.53 | |||||||||
| 3982 | DNA ligase D | 1.05 | ||||||||||
| 4092 | DNA repair protein RadA | 1.22 | 0.89 | 1.39 | 1.72 | |||||||
| 4209 | Glutathione-dependent formaldehyde-activating, GFA | 1.82 | ||||||||||
| 5282 | DNA ligase D | 1.12 | 1.93 | |||||||||
| 5311 | Catalase | 1.27 | ||||||||||
| 0001 | Chromosomal replication initiator protein DnaA | 0.68 | ||||||||||
| 2767 = 3050 = 4905 = 5124 | IS4 family transposase | 1.21 | 0.90 | 1.04 | 1.26 | |||||||
| 4903 | Transposase IS3/IS911 family protein | 1.26 | 0.83 | 0.51 | 0.36 | 0.52 | ||||||
| 4930 | Transposase Tn3 family protein | 1.96 | 1.89 | 0.95 | 0.93 | 1.16 | 0.96 | |||||
| 5075 | Transposase Tn3 family protein | 1.47 | 1.33 | 1.19 | 1.23 | |||||||
| 5078 | Transposase IS66 | 0.97 | 1.05 | 1.34 | 1.46 | |||||||
| 5109 | IS4 family transposase | 1.99 | 1.16 | 1.24 | 1.16 | 1.30 | ||||||
| 0431 | RNA polymerase sigma factor RpoD | 0.54 | 0.62 | 0.65 | 0.63 | 0.85 | ||||||
| 1325 | Ribosomal protein L17 | 0.53 | ||||||||||
| 1358 | Ribosomal protein S12 | 0.47 | ||||||||||
| 3924 | ECF subfamily RNA polymerase sigma 24 factor | 1.16 | ||||||||||
| 3972 | ECF subfamily RNA polymerase sigma 24 factor | 1.54 | 1.17 | 0.92 | 1.09 | 1.47 | ||||||
| 4736 | ECF subfamily RNA polymerase sigma 24 factor | 1.27 | 0.94 | 1.27 | 1.42 | 1.49 | ||||||
.
.
Figure 4Compilation of possible encoded aromatic compound degradation pathways in . Numbers below arrows correspond to gene names (e.g., Swit_5101). Thick arrows indicate gene induction during growth on SAL or DBF compared to PHE. Gray arrows point to induction on SAL only. Crosses indicate genes in which no transposon insertions were found after 50 generations growth on DBF. Pathway predictions were done using KEGG and NCBI.